Renjen Pushpendra Nath, Khanna Laxmi, Rastogi Ruchi, Khan Nadeem Israr
Department of Neurology, Indraprastha Apollo Hospital, New Delhi, India.
BMJ Case Rep. 2013 Jun 18;2013:bcr2013009387. doi: 10.1136/bcr-2013-009387.
Acquired (non-Wilsonian) hepatocerebral degeneration is a rare irreversible neurological syndrome that occurs in patients with chronic liver disease associated with multiple metabolic insults. Van Woerkom was the first to describe acquired hepatocerebral degeneration in 1914 followed by the landmark article by Victor et al in 1965. Multiple bouts of hepatic coma are the only known risk factors that trigger this devastating neurodegenerative disease with features suggesting toxic exposure to the brain. Clinically and pathologically the disorder is similar to Wilson's disease although subtle differences in immunostaining of glial fibrillar acidic protein have been documented. Acquired hepatocerebral degeneration occurs in 0.8-2% of patients with cirrhosis. As acquired hepatocerebral degeneration is relatively rare, we are reporting one such case from our hospital in a 50-year-old male patient who had long-standing portal systemic shunt and presented with progressive cognitive decline, bradykinesia, tremors and bilateral extrapyramidal signs.
获得性(非威尔逊氏病)肝脑变性是一种罕见的不可逆性神经综合征,发生于患有与多种代谢损伤相关的慢性肝病患者。1914年,范·沃科姆首次描述了获得性肝脑变性,随后1965年维克托等人发表了具有里程碑意义的文章。多次肝昏迷发作是引发这种具有脑部中毒暴露特征的毁灭性神经退行性疾病的唯一已知危险因素。在临床和病理上,该疾病与威尔逊氏病相似,尽管已记录到胶质纤维酸性蛋白免疫染色存在细微差异。获得性肝脑变性在0.8%-2%的肝硬化患者中发生。由于获得性肝脑变性相对罕见,我们报告我院的一例此类病例,患者为一名50岁男性,有长期门体分流病史,表现为进行性认知衰退、运动迟缓、震颤和双侧锥体外系体征。